Cardiovascular Assessment of Pediatric Cancer Survivors

Istanbul University54 enrolled

Overview

The goal of this observational study is to evaluate cardiac and vascular health status of pediatric cancer survivors.

All pediatric cancer survivors were evaluated with cardiological examination, ECG, transthoracic echocardiography (transesophageal echocardiography when required), NT-proBNP, cTnI, kidney function tests, liver function tests, fasting blood glucose, cholesterol panel, iron, iron binding capacity, ferritin, transferrin saturation, B12, vitamin D, folic acid, urinanalysis, hemogram and a questionnaire about living with heart failure.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Left Ventricular Dysfunction Heart Failure

Interventions

ECG, Echocardiography, cTnI, NT-ProBNPDIAGNOSTIC_TEST

All pediatric cancer survivors are evaluated with cardiological examination, ECG, transthoracic echocardiography (transesophageal echocardiography when required), NT-proBNP, cTnI, kidney function tests, liver function tests, fasting blood glucose, cholesterol panel, iron, iron binding capacity, ferritin, transferrin saturation, B12, vitamin D, folic acid, urinanalysis, hemogram and a questionnaire about living with heart failure.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosed cancer at pediatric age Exclusion Criteria: * Having cancer after 18 years of age

Locations (1)

Istanbul Faculty of Medicine

Fatih, Istanbul, Turkey (Türkiye)

Outcomes

Primary Outcomes

Rate of LV Dysfunction

Echocardiographic evaluation of left ventricular functions

Time frame: From the first visit at cardio-oncology division through study completion, an average of 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.